Is It Time To Reconsider Abbott Laboratories (ABT) After Recent Share Price Weakness? [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
This article examines whether Abbott Laboratories, at around US$104 a share, is starting to look interesting or still pricing in too much optimism, and walks through what the current valuation suggests. The stock is down 6.0% over the past week, 7.3% over the past month, and 16.2% year to date, leaving the 1 year return at 15.6% and the 5 year return at 4.8%. These moves sit against a backdrop of ongoing attention on Abbott Laboratories as a large, diversified healthcare name, with investors weighing its role in areas such as diagnostics, medical devices, and nutrition. Recent discussion has focused on how its broad business mix and sector exposure might affect sentiment and risk appetites, which can feed directly into pricing. On Simply Wall St's valuation checks, Abbott Laboratories scores 5 out of 6 for being undervalued, as shown in its valuation score . The next sections will break down what different valuation methods indicate about that number, then finish with a more co
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott hosts conference call for first-quarter earningsPR Newswire
- John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screeningPR Newswire
- Abbott (ABT) Stock Rated Buy on Strong Diabetes Trial Results [Yahoo! Finance]Yahoo! Finance
- Medtronic's OmniaSecure defib lead nets another FDA approval [Yahoo! Finance]Yahoo! Finance
- Abbott completes acquisition of Exact SciencesPR Newswire
ABT
Earnings
- 1/22/26 - In-Line
ABT
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/25/26 - Form 4
- 3/25/26 - Form 3
- ABT's page on the SEC website